Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism B1 receptor modulators(Bradykinin B1 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cancer | Phase 2 | CN | 11 May 2023 | |
Lung Cancer | Preclinical | CN | 11 May 2023 |